vs
CROWN CRAFTS INC（CRWS）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
CROWN CRAFTS INC的季度营收约是STANDARD BIOTOOLS INC.的1.1倍（$20.7M vs $19.6M），CROWN CRAFTS INC净利率更高（7.3% vs -177.4%，领先184.7%），CROWN CRAFTS INC同比增速更快（-11.3% vs -11.5%），CROWN CRAFTS INC自由现金流更多（$2.3M vs $-23.1M），过去两年CROWN CRAFTS INC的营收复合增速更高（-6.7% vs -12.2%）
皇冠工艺品公司是一家美国上市企业，总部位于路易斯安那州冈萨雷斯，主营婴幼儿及青少年消费品的设计、营销与分销业务，公司股票在纳斯达克资本市场挂牌交易，股票代码为CRWS。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
CRWS vs LAB — 直观对比
营收规模更大
CRWS
是对方的1.1倍
$19.6M
营收增速更快
CRWS
高出0.2%
-11.5%
净利率更高
CRWS
高出184.7%
-177.4%
自由现金流更多
CRWS
多$25.4M
$-23.1M
两年增速更快
CRWS
近两年复合增速
-12.2%
损益表 — Q3 FY2026 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $20.7M | $19.6M |
| 净利润 | $1.5M | $-34.7M |
| 毛利率 | 23.5% | 48.5% |
| 营业利润率 | -0.5% | -168.5% |
| 净利率 | 7.3% | -177.4% |
| 营收同比 | -11.3% | -11.5% |
| 净利润同比 | 69.1% | -28.8% |
| 每股收益（稀释后） | — | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRWSLAB
| Q4 25 | $20.7M | — | ||
| Q3 25 | $23.7M | $19.6M | ||
| Q2 25 | $15.5M | $21.8M | ||
| Q1 25 | $23.2M | $40.8M | ||
| Q4 24 | $23.4M | — | ||
| Q3 24 | $24.5M | $22.1M | ||
| Q2 24 | $16.2M | $22.5M | ||
| Q1 24 | — | $45.5M |
净利润CRWSLAB
| Q4 25 | $1.5M | — | ||
| Q3 25 | $1.2M | $-34.7M | ||
| Q2 25 | $-1.1M | $-33.5M | ||
| Q1 25 | $-10.8M | $-26.0M | ||
| Q4 24 | $893.0K | — | ||
| Q3 24 | $860.0K | $-26.9M | ||
| Q2 24 | $-322.0K | $-45.7M | ||
| Q1 24 | — | $-32.2M |
毛利率CRWSLAB
| Q4 25 | 23.5% | — | ||
| Q3 25 | 27.7% | 48.5% | ||
| Q2 25 | 22.7% | 48.8% | ||
| Q1 25 | 18.3% | 48.4% | ||
| Q4 24 | 26.1% | — | ||
| Q3 24 | 28.4% | 54.9% | ||
| Q2 24 | 24.5% | 46.1% | ||
| Q1 24 | — | 53.1% |
营业利润率CRWSLAB
| Q4 25 | -0.5% | — | ||
| Q3 25 | 7.9% | -168.5% | ||
| Q2 25 | -7.7% | -118.1% | ||
| Q1 25 | -60.7% | -80.8% | ||
| Q4 24 | 7.3% | — | ||
| Q3 24 | 6.2% | -120.9% | ||
| Q2 24 | -1.8% | -134.5% | ||
| Q1 24 | — | -132.2% |
净利率CRWSLAB
| Q4 25 | 7.3% | — | ||
| Q3 25 | 4.9% | -177.4% | ||
| Q2 25 | -7.1% | -153.7% | ||
| Q1 25 | -46.4% | -63.8% | ||
| Q4 24 | 3.8% | — | ||
| Q3 24 | 3.5% | -122.0% | ||
| Q2 24 | -2.0% | -203.3% | ||
| Q1 24 | — | -70.6% |
每股收益（稀释后）CRWSLAB
| Q4 25 | — | — | ||
| Q3 25 | — | $-0.09 | ||
| Q2 25 | $-0.10 | $-0.09 | ||
| Q1 25 | — | $-0.07 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-0.07 | ||
| Q2 24 | $-0.03 | $-0.12 | ||
| Q1 24 | — | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.4M | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $39.2M | $399.7M |
| 总资产 | $76.1M | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CRWSLAB
| Q4 25 | $2.4M | — | ||
| Q3 25 | $810.0K | $129.4M | ||
| Q2 25 | $227.0K | $158.6M | ||
| Q1 25 | $521.0K | $150.9M | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $2.0M | $210.6M | ||
| Q2 24 | $1.1M | $269.8M | ||
| Q1 24 | — | $287.1M |
总债务CRWSLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
股东权益CRWSLAB
| Q4 25 | $39.2M | — | ||
| Q3 25 | $38.4M | $399.7M | ||
| Q2 25 | $37.9M | $424.5M | ||
| Q1 25 | $39.6M | $454.6M | ||
| Q4 24 | $51.1M | — | ||
| Q3 24 | $50.8M | $489.3M | ||
| Q2 24 | $50.7M | $510.3M | ||
| Q1 24 | — | $577.3M |
总资产CRWSLAB
| Q4 25 | $76.1M | — | ||
| Q3 25 | $77.5M | $539.6M | ||
| Q2 25 | $76.0M | $557.0M | ||
| Q1 25 | $81.2M | $579.6M | ||
| Q4 24 | $98.7M | — | ||
| Q3 24 | $99.3M | $681.5M | ||
| Q2 24 | $76.4M | $708.7M | ||
| Q1 24 | — | $777.7M |
负债/权益比CRWSLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.7M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $2.3M | $-23.1M |
| 自由现金流率自由现金流/营收 | 11.3% | -118.1% |
| 资本支出强度资本支出/营收 | 1.7% | 4.5% |
| 现金转化率经营现金流/净利润 | 1.78× | — |
| 过去12个月自由现金流最近4个季度 | $9.1M | $-111.1M |
8季度趋势，按日历期对齐
经营现金流CRWSLAB
| Q4 25 | $2.7M | — | ||
| Q3 25 | $-845.0K | $-22.2M | ||
| Q2 25 | $5.2M | $-20.7M | ||
| Q1 25 | $2.8M | $-30.3M | ||
| Q4 24 | $-36.0K | — | ||
| Q3 24 | $-983.0K | $-27.9M | ||
| Q2 24 | $8.0M | $-39.0M | ||
| Q1 24 | — | $-62.5M |
自由现金流CRWSLAB
| Q4 25 | $2.3M | — | ||
| Q3 25 | $-1.0M | $-23.1M | ||
| Q2 25 | $5.2M | $-22.6M | ||
| Q1 25 | $2.6M | $-35.3M | ||
| Q4 24 | $-220.0K | — | ||
| Q3 24 | $-1.2M | $-30.1M | ||
| Q2 24 | $7.7M | $-41.0M | ||
| Q1 24 | — | $-63.3M |
自由现金流率CRWSLAB
| Q4 25 | 11.3% | — | ||
| Q3 25 | -4.3% | -118.1% | ||
| Q2 25 | 33.4% | -103.6% | ||
| Q1 25 | 11.3% | -86.6% | ||
| Q4 24 | -0.9% | — | ||
| Q3 24 | -4.8% | -136.4% | ||
| Q2 24 | 47.7% | -182.2% | ||
| Q1 24 | — | -138.9% |
资本支出强度CRWSLAB
| Q4 25 | 1.7% | — | ||
| Q3 25 | 0.7% | 4.5% | ||
| Q2 25 | 0.6% | 8.7% | ||
| Q1 25 | 0.9% | 12.4% | ||
| Q4 24 | 0.8% | — | ||
| Q3 24 | 0.8% | 10.2% | ||
| Q2 24 | 1.8% | 8.6% | ||
| Q1 24 | — | 1.7% |
现金转化率CRWSLAB
| Q4 25 | 1.78× | — | ||
| Q3 25 | -0.73× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.04× | — | ||
| Q3 24 | -1.14× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRWS
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
